期刊文献+

恶性腹水的内科处理进展 被引量:20

Advances of medical management in malignant ascites
暂未订购
导出
摘要 恶性腹水是指恶性肿瘤导致的腹腔积液的异常增多,可以引起腹胀、恶心、呕吐、厌食、呼吸困难以及肢体水肿,继而引起患者的生活质量下降。目前,不同的治疗措施尚缺乏很好的循证医学证据以及缺乏公认的处理指南。对于临床医师的挑战是如何最佳处理恶性腹水,以达到最佳的治疗效果。本文现对恶性腹水的内科处理方法做一综述。 Malignant ascites (MA) are the cancer-associated accumulation of fluids in the peritoneal cavity. Symptoms in- clude abdominal distention, nausea, vomiting, anorexia, dyspnea and limbs oedemas, producing a significant reduction in the patients' quality of life. Currently, none of the different options has been subjected to evidence-based clinical trials and there are no accepted guidelines for the management of MA. The challenge for clinicians is to know how to best manage the symptoms of MA patients for opti- mal outcomes. The purpose of this article is to discuss critically the medical management of MA.
出处 《临床肿瘤学杂志》 CAS 2013年第5期472-474,共3页 Chinese Clinical Oncology
基金 安徽省自然科学基金资助项目(070413256X) 2010年安徽省卫生厅医学科研课题(2010B001)
关键词 恶性腹水 生活质量 内科处理 Malignant ascites Quality of life Medical management
  • 相关文献

参考文献2

二级参考文献17

  • 1Smith EM, Jayson GC. The current and future management of malignant ascites [ J ]. Clin Oncol ( R Coll Radiol) , 2003, 15 (2) :59 -72.
  • 2Runyon BA. Care of patients with ascites[ J ]. N Engl J Med, 1994, 330(5) :337 -342.
  • 3Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study[ J]. Ann Oncol, 2007, 18(5) :945 -949.
  • 4Verheul HM, Hoekmann K, Jorna AS, et al. Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation [ J ]. Oncologist, 2000, 5 ( Suppl 1 ) : 45 - 50.
  • 5Shichiri M, Hirata Y. Antiangiogenesis signals by endostatin [J]. FASEB J, 2001, 15(6) : 1044 - 1053.
  • 6Huang X, Wong MK, Zhao Q, et al. Soluble reeombinant endostatin purified from Escherichia coli: antiangiogenic activity and antitumor effect [ J]. Cancer Res, 2001, 61 ( 2 ) : 478 -481.
  • 7Xu F, Ma Q, Sha H. Optimizing drug delivery fbr enhancing therapeutic efficacy of recombinant human endostatin in cancer treatment[ J ]. Crit Rev Ther Drug Carrier Syst, 2007, 24 (5) : 445 - 492
  • 8Wu Y, Yang L, Hu B, et al. Synergistic antitumor effect of recombinant human endostatin adenovirus combined with gemeitabine[ J]. Anticancer Drugs, 2005, 16(5) : 551 -557.
  • 9Tamsma JT,Keizer H J, Meinders AE. Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited [ J ]. Ann Oncol, 2001, 12(10): 1353-1357.
  • 10Liu CD, Tilch L, Kwan D, et al. Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer[J]. J Surg Res, 2002,102(1):31 -34.

共引文献96

同被引文献199

引证文献20

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部